Search

Your search keyword '"Al-Ahmad, M."' showing total 359 results

Search Constraints

Start Over You searched for: Author "Al-Ahmad, M." Remove constraint Author: "Al-Ahmad, M."
359 results on '"Al-Ahmad, M."'

Search Results

1. Effect of Dupilumab on Radiological Remission in Patients with Chronic Rhinosinusitis with Nasal Polyp: A One Step Forward Toward Clinical Remission

2. Interleukin-4 (C590T) Gene Polymorphism in Association with Asthma Severity

3. Adult Severe Asthma Registries: A Global and Growing Inventory

4. Management of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in the Pan-Arab Region: Consensus Recommendations from a Multidisciplinary Expert Working Group

5. Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy

6. Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study

7. Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region

8. International Variation in Exacerbation Rates in Patients With Severe Asthma

9. Unveiling the Real-World Causal Interaction of Essential Risk Factors in Severe Asthma Exacerbation: A Bayesian Network Analysis

10. Bilirubin detoxification using different phytomaterials: characterization and in vitro studies

11. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

12. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

13. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

14. Economic burden of refractory chronic spontaneous urticaria on Kuwait's health system

15. The ARIA-MeDALL hypothesis

17. Modeling of Cutting Forces in Plunge Milling

18. Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma

19. Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients

20. Physicians' preferences in the use of PROMs during asthma and allergic rhinitis clinical approach

21. Effectiveness of initiating biologics in severe asthma patients with high steroid exposure

24. Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study.

25. Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy

26. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

27. Adrenaline autoinjector is underprescribed in typical cold urticaria patients

28. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

30. Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study

31. Management of anaphylaxis due to COVID-19 vaccines in the elderly

33. Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.

39. The global burden of chronic urticaria for the patient and society*

40. A Global Survey of Blood Eosinophil Distribution in Severe Asthma Patients: Data from the International Severe Asthma Registry (ISAR)

41. Characterization of Eosinophilic and Non-Eosinophilic Severe Asthma Phenotypes and Proportion of Patients with These Phenotypes in the International Severe Asthma Registry (ISAR)

42. Biologic Utilization Patterns: Data from the International Severe Asthma Registry (ISAR)

43. Global Access for Biologics in the Treatment of Severe Asthma: A Challenge to Personalized Medicine

45. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

46. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

48. The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

49. Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence

Catalog

Books, media, physical & digital resources